• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人及动物围生期组织来源的间充质干细胞:起源、特性、信号通路及临床试验。

Mesenchymal Stem/Stromal Cells Derived from Human and Animal Perinatal Tissues-Origins, Characteristics, Signaling Pathways, and Clinical Trials.

机构信息

Department of Veterinary Surgery, Institute of Veterinary Medicine, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.

Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland.

出版信息

Cells. 2021 Nov 23;10(12):3278. doi: 10.3390/cells10123278.

DOI:10.3390/cells10123278
PMID:34943786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8699543/
Abstract

Mesenchymal stem/stromal cells (MSCs) are currently one of the most extensively researched fields due to their promising opportunity for use in regenerative medicine. There are many sources of MSCs, of which cells of perinatal origin appear to be an invaluable pool. Compared to embryonic stem cells, they are devoid of ethical conflicts because they are derived from tissues surrounding the fetus and can be safely recovered from medical waste after delivery. Additionally, perinatal MSCs exhibit better self-renewal and differentiation properties than those derived from adult tissues. It is important to consider the anatomy of perinatal tissues and the general description of MSCs, including their isolation, differentiation, and characterization of different types of perinatal MSCs from both animals and humans (placenta, umbilical cord, amniotic fluid). Ultimately, signaling pathways are essential to consider regarding the clinical applications of MSCs. It is important to consider the origin of these cells, referring to the anatomical structure of the organs of origin, when describing the general and specific characteristics of the different types of MSCs as well as the pathways involved in differentiation.

摘要

间充质干细胞(MSCs)是目前研究最广泛的领域之一,因为它们在再生医学中有很大的应用潜力。MSCs 有很多来源,其中来自围产期的细胞似乎是一个非常有价值的来源。与胚胎干细胞相比,它们没有伦理冲突,因为它们是从胎儿周围的组织中提取的,可以在分娩后从医疗废物中安全回收。此外,围产期 MSCs 比来自成人组织的 MSCs 具有更好的自我更新和分化特性。重要的是要考虑围产期组织的解剖结构和 MSCs 的一般描述,包括从动物和人类(胎盘、脐带、羊水)中分离、分化和鉴定不同类型围产期 MSCs 的特征。最终,在考虑 MSCs 的临床应用时,信号通路是至关重要的。在描述不同类型 MSCs 的一般和特定特征以及分化涉及的途径时,必须考虑这些细胞的起源,即起源器官的解剖结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/e578ab2c4bbe/cells-10-03278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/69909bc9cb98/cells-10-03278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/a131e06d131f/cells-10-03278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/e578ab2c4bbe/cells-10-03278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/69909bc9cb98/cells-10-03278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/a131e06d131f/cells-10-03278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f797/8699543/e578ab2c4bbe/cells-10-03278-g003.jpg

相似文献

1
Mesenchymal Stem/Stromal Cells Derived from Human and Animal Perinatal Tissues-Origins, Characteristics, Signaling Pathways, and Clinical Trials.人及动物围生期组织来源的间充质干细胞:起源、特性、信号通路及临床试验。
Cells. 2021 Nov 23;10(12):3278. doi: 10.3390/cells10123278.
2
Human placental stem cells: biomedical potential and clinical relevance.人胎盘干细胞:生物医学潜力与临床相关性。
J Stem Cells. 2011;6(2):75-92.
3
Generation of functional islets from human umbilical cord and placenta derived mesenchymal stem cells.从人脐带和胎盘来源的间充质干细胞生成功能性胰岛。
Methods Mol Biol. 2012;879:291-313. doi: 10.1007/978-1-61779-815-3_17.
4
Current Status and Future Prospects of Perinatal Stem Cells.围产期干细胞的现状与展望。
Genes (Basel). 2020 Dec 23;12(1):6. doi: 10.3390/genes12010006.
5
Mesenchymal stromal cell characteristics vary depending on their origin.间充质基质细胞的特征因其起源而异。
Stem Cells Dev. 2013 Oct 1;22(19):2606-18. doi: 10.1089/scd.2013.0016. Epub 2013 Jun 22.
6
The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.羊膜和羊水来源的间充质干细胞在神经再生治疗中的潜力。
BMB Rep. 2014 Mar;47(3):135-40. doi: 10.5483/bmbrep.2014.47.3.289.
7
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition.无血清条件下羊膜、脐带和胎盘绒毛膜来源间充质干细胞的比较分析。
Stem Cell Res Ther. 2019 Jan 11;10(1):19. doi: 10.1186/s13287-018-1104-x.
8
Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.胚胎干细胞衍生的间充质干细胞(MSCs)在缺氧缺血性小鼠脑中比胎儿MSCs具有更强的神经保护能力。
Stem Cells Transl Med. 2018 May;7(5):439-449. doi: 10.1002/sctm.17-0260. Epub 2018 Feb 28.
9
Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord.比较人胎盘和脐带来源间充质干细胞的生物学特性。
Sci Rep. 2018 Mar 22;8(1):5014. doi: 10.1038/s41598-018-23396-1.
10
An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine.人根尖周囊肿-间充质干细胞及其在再生医学中应用的研究进展。
Mol Biol Rep. 2020 Mar;47(3):2381-2389. doi: 10.1007/s11033-020-05298-6. Epub 2020 Feb 6.

引用本文的文献

1
Mesenchymal stem cell therapy in veterinary orthopaedics: Evidence from canine clinical medicine.兽医骨科中的间充质干细胞疗法:来自犬类临床医学的证据。
Vet Res Commun. 2025 Aug 28;49(5):290. doi: 10.1007/s11259-025-10843-4.
2
Xenotransplantation of Human Umbilical Mesenchymal Stromal Cells Derived from Wharton's Jelly Mitigates Mouse Amyotrophic Lateral Sclerosis.源自华通氏胶的人脐带间充质基质细胞的异种移植减轻小鼠肌萎缩侧索硬化症
Stem Cell Res Ther. 2025 Jul 22;16(1):395. doi: 10.1186/s13287-025-04485-1.
3
Dynamic changes in BDNF, VEGF, and GDNF after transplanting human protein-based scaffolds with Wharton's Jelly MSCs in a rat brain injury model.

本文引用的文献

1
Development and investigational new drug application of mesenchymal stem/stromal cells products in China.中国间充质干细胞/基质细胞产品的研发和新药临床试验申请。
Stem Cells Transl Med. 2021 Nov;10 Suppl 2(Suppl 2):S18-S30. doi: 10.1002/sctm.21-0083.
2
Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?基于间充质基质细胞的临床试验呈指数级增长:近年来我们取得了哪些进展?
Stem Cell Rev Rep. 2022 Jan;18(1):23-36. doi: 10.1007/s12015-021-10231-w. Epub 2021 Aug 16.
3
Age-related alterations and senescence of mesenchymal stromal cells: Implications for regenerative treatments of bones and joints.
在大鼠脑损伤模型中移植含华通氏胶间充质干细胞的基于人类蛋白质的支架后,脑源性神经营养因子(BDNF)、血管内皮生长因子(VEGF)和胶质细胞源性神经营养因子(GDNF)的动态变化。
Sci Rep. 2025 Jul 2;15(1):22625. doi: 10.1038/s41598-025-04269-w.
4
Effects of Small Extracellular Vesicles Derived From Mesenchymal Stromal Cells on Acute Kidney Injury: A Rat Ischemia-Reperfusion Model.间充质基质细胞来源的小细胞外囊泡对急性肾损伤的影响:大鼠缺血再灌注模型
Cureus. 2025 May 19;17(5):e84411. doi: 10.7759/cureus.84411. eCollection 2025 May.
5
Advancements in Stem Cell Research for Effective Therapies Against Alzheimer's Disease: Current Investigation and Future Insight.用于有效治疗阿尔茨海默病的干细胞研究进展:当前调查与未来展望
Mol Neurobiol. 2025 May 6. doi: 10.1007/s12035-025-05003-3.
6
Intelligent Manufacturing for Osteoarthritis Organoids.骨关节炎类器官的智能制造
Cell Prolif. 2025 Apr 26:e70043. doi: 10.1111/cpr.70043.
7
Effectiveness and safety of multiple injections of human placenta-derived MSCs for knee osteoarthritis: a nonrandomized phase I trial.多次注射人胎盘源间充质干细胞治疗膝骨关节炎的有效性和安全性:一项非随机I期试验
BMC Musculoskelet Disord. 2025 Apr 26;26(1):418. doi: 10.1186/s12891-025-08664-2.
8
Mesenchymal stem cells and their derivatives as potential longevity-promoting tools.间充质干细胞及其衍生物作为潜在的促进长寿工具。
Biogerontology. 2025 Apr 21;26(3):96. doi: 10.1007/s10522-025-10240-z.
9
Emerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment.间充质基质细胞和外泌体疗法在治疗认知障碍中的新兴作用
Pharmaceutics. 2025 Feb 20;17(3):284. doi: 10.3390/pharmaceutics17030284.
10
Exosomal miR-125b-5p derived from mesenchymal stromal/stem cell enhances anti-PD-1 therapy in mouse colon cancer model.源自间充质基质/干细胞的外泌体miR-125b-5p增强小鼠结肠癌模型中的抗PD-1治疗效果。
Stem Cell Res Ther. 2025 Mar 5;16(1):112. doi: 10.1186/s13287-025-04227-3.
间质基质细胞的衰老与年龄相关:对骨骼和关节再生治疗的影响。
Mech Ageing Dev. 2021 Sep;198:111539. doi: 10.1016/j.mad.2021.111539. Epub 2021 Jul 7.
4
Age-Related Changes in Bone-Marrow Mesenchymal Stem Cells.骨髓间充质干细胞的年龄相关性变化。
Cells. 2021 May 21;10(6):1273. doi: 10.3390/cells10061273.
5
Analysis of Key Distinct Biological Characteristics of Human Placenta-Derived Mesenchymal Stromal Cells and Individual Heterogeneity Attributing to Donors.人胎盘来源间充质基质细胞的关键独特生物学特性及供体所致个体异质性分析
Cells Tissues Organs. 2021;210(1):45-57. doi: 10.1159/000513038. Epub 2021 Mar 29.
6
Human placenta-derived mesenchymal stem cells induce trophoblast invasion via dynamic effects on mitochondrial function.人胎盘间充质干细胞通过对线粒体功能的动态影响诱导滋养层细胞侵袭。
J Cell Physiol. 2021 Sep;236(9):6678-6690. doi: 10.1002/jcp.30330. Epub 2021 Feb 24.
7
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.人脐带间充质干细胞对重症 COVID-19 患者肺损伤的影响:一项随机、双盲、安慰剂对照的 2 期试验。
Signal Transduct Target Ther. 2021 Feb 10;6(1):58. doi: 10.1038/s41392-021-00488-5.
8
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.围生期组织来源的间充质干细胞治疗危重症 COVID-19 诱导的 ARDS 患者:病例系列。
Stem Cell Res Ther. 2021 Jan 29;12(1):91. doi: 10.1186/s13287-021-02165-4.
9
Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature.围产期衍生物:我们目前的状况如何?人类胎盘路线图及组织和细胞命名共识。
Front Bioeng Biotechnol. 2020 Dec 17;8:610544. doi: 10.3389/fbioe.2020.610544. eCollection 2020.
10
Current Status and Future Prospects of Perinatal Stem Cells.围产期干细胞的现状与展望。
Genes (Basel). 2020 Dec 23;12(1):6. doi: 10.3390/genes12010006.